Author:
Kähler K.C.,Egberts F.,Hauschild A.
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Balch CM, Buzaid AC, Soong SJ et al (2001) Final version of the American Joint Committee on Cacer staging system for cutaneous melanoma. J Clin Oncol 15:3535–3648
2. Hill GJ, Moss SE, Golomb FM et al (1981) DTIC and combination therapy for melanoma, III: DTIC surgical adjuvant study COG protocol 7040. Cancer 47:2556–2562
3. Karg C, Garbe C, Orfanos CE (1990) Chemotherapie des malignen Melanoms –aktueller Stand. Hautarzt 41:56–65
4. Veronesi U, Adamus J, Aubert C (1982) A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. N Engl J Med 307:913–916
5. Garbe C, Radny P, Linse R et al (2008) Adjuvant low-dose interferon alpha-2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis. Ann Oncol 19:1195–201. Epub 2008 Feb 14